Related Experiment Video
Updated: Nov 7, 2025

Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy
Published on: October 19, 2016
Arterial stiffness: A brief review
Jen-Pi Tsai1,2, Bang-Gee Hsu1,3
1School of Medicine, Tzu Chi University, Hualien, Taiwan.
Insights
Arterial stiffness (AS) predicts cardiovascular disease (CVD), particularly in chronic kidney disease (CKD) patients. Understanding AS risk factors, measurement, and treatments is crucial for managing CVD risk.
Area of Science:
- Cardiovascular Medicine
- Nephrology
Background:
- Arterial stiffness (AS) is an independent predictor of cardiovascular disease (CVD), especially in patients with chronic kidney disease (CKD).
- CKD patients exhibit high CVD prevalence, with AS identified as a significant non-traditional risk factor contributing to this elevated risk.
- Mechanisms underlying AS development include oxidative stress, inflammation, uremic toxins, vascular calcification, and traditional cardiovascular risk factors.
Purpose of the Study:
- To review the risk factors, measurement techniques, and treatment options for arterial stiffness.
- To highlight the association between arterial stiffness and cardiovascular disease in the context of chronic kidney disease.
Main Methods:
- Review of existing literature on arterial stiffness, its risk factors, and measurement methods.
- Focus on carotid-femoral pulse wave velocity as the reference standard for AS measurement.
- Discussion of current therapeutic interventions for AS progression.
Main Results:
- Arterial stiffness is linked to multiple diseases, aging, and significantly predicts CVD outcomes, particularly in CKD.
- Carotid-femoral pulse wave velocity is the established reference method for quantifying AS and correlates with long-term CVD events.
- Current medical treatments for AS progression demonstrate modest beneficial effects.
Conclusions:
- Arterial stiffness is a critical factor in cardiovascular risk assessment, especially for individuals with chronic kidney disease.
- Accurate measurement of AS using methods like pulse wave velocity is essential for predicting cardiovascular outcomes.
- Further research into effective treatments for arterial stiffness is warranted to mitigate cardiovascular risk in affected populations.
Abstract:
Apart from the result of multiple diseases as well as aging, arterial stiffness (AS) predicts cardiovascular disease (CVD), especially in patients with chronic kidney disease (CKD). Patients with CKD have high CVD prevalence, and an extraordinarily high risk for CVD might be related to nontraditional risk factors, including AS. The mechanism of AS development could be attributed to oxidative stress, inflammation, uremic milieu (e.g., uremic toxins), vascular calcification, and cumulative effects of traditional cardiovascular risk factors on arteries such as diabetes mellitus or hypertension. There were a variety of non-invasive techniques to measure AS. One of these techniques is carotid-femoral pulse wave velocity, which is the reference measurement of AS and is related to long-term CVD outcomes. AS progression has corresponding medical treatments with modest beneficial results. This review briefly discusses the risk factors, measurements, and treatments associated with AS.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Assessment of blood pressure in brachial artery(two-step method)
Autoregulation of Blood Flow
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
Arteries of Lower Limbs

